Volume 15 (2008): Issue 1 (Mar 2008)

in Endocrine-Related Cancer
Online ISSN:
1479-6821
Print ISSN:
1351-008

Articles are added to the current issue and list of accepted manuscripts on an ongoing basis, reflecting the journal's continuous publication.

Sign up using the button to receive email notifications of the latest research.

Sign up for journal news
Modulation of proteomic profile in H295R adrenocortical cell line induced by mitotane
Author(s): A Stigliano, L Cerquetti, M Borro, G Gentile, B Bucci, S Misiti, P Piergrossi, E Brunetti, M Simmaco, and V Toscano
Pages: 1–10
The emergence of DNA methylation as a key modulator of aberrant cell death in prostate cancer
Author(s): T M Murphy, A S Perry, and M Lawler
Pages: 11–25
Aromatase inhibitors for breast cancer: different structures, same effects?
Author(s): Riccardo Ponzone, Paola Mininanni, Elisa Cassina, Francesca Pastorino, and Piero Sismondi
Pages: 27–36
Bone metastases from differentiated thyroid carcinoma
Author(s): M M Muresan, P Olivier, J Leclère, F Sirveaux, L Brunaud, M Klein, R Zarnegar, and G Weryha
Pages: 37–49
Thyroid stem cells: lessons from normal development and thyroid cancer
Author(s): Dolly Thomas, Susan Friedman, and Reigh-Yi Lin
Pages: 51–58
Transforming growth factor-β signaling and ubiquitinators in cancer
Author(s): Eric Glasgow and Lopa Mishra
Pages: 59–72
Menopausal symptoms and adjuvant therapy-associated adverse events
Author(s): P Hadji
Pages: 73–90
Arachidonic acid modulates the crosstalk between prostate carcinoma and bone stromal cells
Author(s): Adriano Angelucci, Stefania Garofalo, Silvia Speca, Antonella Bovadilla, Giovanni Luca Gravina, Paola Muzi, Carlo Vicentini, and Mauro Bologna
Pages: 91–100
Fibroblast growth factor receptor 4 predicts failure on tamoxifen therapy in patients with recurrent breast cancer
Author(s): Danielle Meijer, Anieta M Sieuwerts, Maxime P Look, Ton van Agthoven, John A Foekens, and Lambert C J Dorssers
Pages: 101–111
Intratumoral concentration of sex steroids and expression of sex steroid-producing enzymes in ductal carcinoma in situ of human breast
Author(s): Rie Shibuya, Takashi Suzuki, Yasuhiro Miki, Kimako Yoshida, Takuya Moriya, Katsuhiko Ono, Jun-ichi Akahira, Takanori Ishida, Hisashi Hirakawa, Dean B Evans, and Hironobu Sasano
Pages: 113–124
ABCC11 expression is regulated by estrogen in MCF7 cells, correlated with estrogen receptor α expression in postmenopausal breast tumors and overexpressed in tamoxifen-resistant breast cancer cells
Author(s): Mylène Honorat, Aurelia Mesnier, Julie Vendrell, Jérôme Guitton, Ivan Bieche, Rosette Lidereau, Gary D Kruh, Charles Dumontet, Pascale Cohen, and Lea Payen
Pages: 125–138
Enhanced expression of aromatase in p53-inactivated mammary epithelial cells
Author(s): Hoo Kyun Choi, Sang Hee Roh, Hyung Gyoun Kim, Eun Hee Han, Hye Gwang Jeong, and Keon Wook Kang
Pages: 139–147
A novel vaccine targeting gastrin-releasing peptide: efficient inhibition of breast cancer growth in vivo
Author(s): Wu Guojun, Guo Wei, Ouyan Kedong, He Yi, Xie Yanfei, Chen Qingmei, Zhang Yankai, Wu Jie, Fan Hao, Li Taiming, Liu Jingjing, and Cao Rongyue
Pages: 149–159
Global gene expression profiles induced by phytoestrogens in human breast cancer cells
Author(s): Ramiro Dip, Sarah Lenz, Jean-Philippe Antignac, Bruno Le Bizec, Hans Gmuender, and Hanspeter Naegeli
Pages: 161–173
Cytological Ki-67 in pancreatic endocrine tumours: an opportunity for pre-operative grading
Author(s): Cecilia Piani, Giulia M Franchi, Chiara Cappelletti, Marina Scavini, Luca Albarello, Alessandro Zerbi, Paolo Giorgio Arcidiacono, Emanuele Bosi, and Marco F Manzoni
Pages: 175–181
Association of the T1799A BRAF mutation with tumor extrathyroidal invasion, higher peripheral platelet counts, and over-expression of platelet-derived growth factor-B in papillary thyroid cancer
Author(s): Yangang Wang, Meiju Ji, Wei Wang, Zhimin Miao, Peng Hou, Xinyan Chen, Feng Xu, Guangwu Zhu, Xianlu Sun, Yujun Li, Steven Condouris, Dingxie Liu, Shengli Yan, Jie Pan, and Mingzhao Xing
Pages: 183–190
BRAF(V600E) mutation and the biology of papillary thyroid cancer
Author(s): F Frasca, C Nucera, G Pellegriti, P Gangemi, M Attard, M Stella, M Loda, V Vella, C Giordano, F Trimarchi, E Mazzon, A Belfiore, and R Vigneri
Pages: 191–205
Familial non-medullary thyroid carcinoma (FNMTC): analysis of fPTC/PRN, NMTC1, MNG1 and TCO susceptibility loci and identification of somatic BRAF and RAS mutations
Author(s): Branca M Cavaco, Pedro F Batista, Carmo Martins, Ana Banito, Francisco do Rosário, Edward Limbert, Luís G Sobrinho, and Valeriano Leite
Pages: 207–215
Deregulation of anti-Mullerian hormone/BMP and transforming growth factor-β pathways in Leydig cell lesions developed in male heterozygous multiple endocrine neoplasia type 1 mutant mice
Author(s): Nader Hussein, JieLi Lu, Huguette Casse, Sandra Fontanière, Anne-Marie Morera, Séverine Mazaud Guittot, Alain Calender, Nathalie Di Clemente, and Chang X Zhang
Pages: 217–227
Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity
Author(s): Nele Garbrecht, Martin Anlauf, Anja Schmitt, Tobias Henopp, Bence Sipos, Andreas Raffel, Claus F Eisenberger, Wolfram T Knoefel, Marianne Pavel, Christian Fottner, Thomas J Musholt, Anja Rinke, Rudolf Arnold, Uta Berndt, Ursula Plöckinger, Bertram Wiedenmann, Holger Moch, Philipp U Heitz, Paul Komminoth, Aurel Perren, and Günter Klöppel
Pages: 229–241
Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysis
Author(s): Eva-Maria Duerr, Yusuke Mizukami, Aylwin Ng, Ramnik J Xavier, Hirotoshi Kikuchi, Vikram Deshpande, Andrew L Warshaw , Jonathan Glickman, Matthew H Kulke, and Daniel C Chung
Pages: 243–256
Antitumor activity of rapamycin and octreotide as single agents or in combination in neuroendocrine tumors
Author(s): Amy Moreno, Argun Akcakanat, Mark F Munsell, Alpana Soni, James C Yao, and Funda Meric-Bernstam
Pages: 257–266
Parathyroid tumor development involves deregulation of homeobox genes
Author(s): H-C Jennifer Shen, Jennifer E Rosen, Lauren M Yang, Sharon A Savage, A Lee Burns, Carmen M Mateo, Sunita K Agarwal, Settara C Chandrasekharappa, Allen M Spiegel, Francis S Collins, Stephen J Marx, and Steven K Libutti
Pages: 267–275
Anti-cancer actions of a recombinant antibody (R6313/G2) against the angiotensin II AT1 receptor
Author(s): M A Redondo-Müller, M Stevanovic-Walker, S Barker, J R Puddefoot, and G P Vinson
Pages: 277–288
Adiponectin receptor expression is elevated in colorectal carcinomas but not in gastrointestinal stromal tumors
Author(s): Catherine J Williams, Nicholas Mitsiades, Elias Sozopoulos, Alex Hsi, Alicja Wolk, Artemissia-Phoebe Nifli, Sofia Tseleni-Balafouta, and Christos S Mantzoros
Pages: 289–299
Characterization of gastrin–cholecystokinin 2 receptor interaction in relation to c-fos induction
Author(s): Martine J Hollestelle, Peter Timmerman, Rob H Meloen, and Jo W M Höppener
Pages: 301–309
Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations
Author(s): Tomáš Zelinka, Henri J L M Timmers, Anna Kozupa, Clara C Chen, Jorge A Carrasquillo, James C Reynolds, Alexander Ling, Graeme Eisenhofer, Ivica Lazúrová, Karen T Adams, Millie A Whatley, Jiří Widimský Jr, and Karel Pacak
Pages: 311–323
The insulin receptor: a new anticancer target for peroxisome proliferator-activated receptor-γ (PPARγ) and thiazolidinedione-PPARγ agonists
Author(s): V Costa, D Foti, F Paonessa, E Chiefari, L Palaia, G Brunetti, E Gulletta, A Fusco, and A Brunetti
Pages: 325–335
Gastric endocrine tumors type I: treatment with long-acting somatostatin analogs
Author(s): D Campana, F Nori, R Pezzilli, L Piscitelli, D Santini, E Brocchi, R Corinaldesi, and P Tomassetti
Pages: 337–342
Overexpression of ERBB-2 was more frequently detected in malignant than benign pheochromocytomas by multiplex ligation-dependent probe amplification and immunohistochemistry
Author(s): WenQi Yuan, WeiQinq Wang, Bin Cui, TingWei Su, Yan Ge, Lei Jiang, WeiWei Zhou, and Guang Ning
Pages: 343–350
Roles of estrogen receptor α and β in modulating urothelial cell proliferation
Author(s): Jian Teng, Zun-Yi Wang, David F Jarrard, and Dale E Bjorling
Pages: 351–364
Erratum
Pages: 365
Erratum
Pages: 366
  • Collapse
  • Expand
Print ISSN:
1351-0088
Online ISSN:
1479-6821